1. Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer
   Ángela Marrugal et al, 2016, Disease Markers CrossRef
2. Prospects for new lung cancer treatments that target EMT signaling
   Yuji Otsuki et al, 2017, Dev. Dyn. CrossRef
3. CXCL12/SDF-1α induces migration via SRC-mediated CXCR4-EGFR cross-talk in gastric cancer cells
   Yu Cheng et al, 2017 CrossRef
4. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
   Bowen Du et al, 2016, Molecules CrossRef
5. trans -3-Methoxy-5-hydroxystilbene (MHS) from the rhizome of Alpinia nantonensis inhibits metastasis in human lung cancer cells
   K.J. Senthil Kumar et al, 2018, Phytomedicine CrossRef
6. The role of non-coding RNAs in regulating epithelial responses in COPD
   Yifan Chen et al, 2018, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
7. Streptococcus gordonii programs epithelial cells to resist ZEB2 induction by Porphyromonas gingivalis
   Jun Ohshima et al, 2019, Proc Natl Acad Sci USA CrossRef
8. Bufalin derivative BF211 inhibits proteasome activity in human lung cancer cells in vitro by inhibiting β1 subunit expression and disrupting proteasome assembly.
   Peng Sun et al, 2016, Acta Pharmacol Sin CrossRef
9. New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
   Chien-shan Cheng et al, 2019, Cancer Cell Int CrossRef
10. Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer
    Fei Cao et al, 2019, Toxicology and Applied Pharmacology CrossRef
11. Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells
    Shi Mao Zhu et al, 2019, Intest Res CrossRef
12. Effect of COA-Cl on transforming growth factor-β1-induced epithelial–mesenchymal transition in RLE/Abca3 cells
    Masashi Kawami et al, 2017, Drug Metabolism and Pharmacokinetics CrossRef
13. RANKL/RANK promotes the migration of gastric cancer cells by interacting with EGFR
    Xing Wan et al, 2020, Clin Trans Med CrossRef
14. Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction
    Katharina Schimmel et al, 2020, Circulation CrossRef
15. Piperine Inhibits TGF-β Signaling Pathways and Disrupts EMT-Related Events in Human Lung Adenocarcinoma Cells
    Leonardo Marques da Fonseca et al, 2020, Medicines CrossRef
16. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway
    Haiyong Wang et al, 2016, Oncotarget CrossRef
17. Molecular mechanisms underlying the�antimetastatic activity of bufalin (Review)
    Jie Wang et al, 2018, mol clin onc CrossRef
18. Bufalin suppresses the proliferation and metastasis of renal cell carcinoma by inhibiting the PI3K/Akt/mTOR signaling pathway.
    Jinlin Xie et al, 0 CrossRef
19. Mediator complex subunit 16 is down-regulated in papillary thyroid cancer, leading to increased transforming growth factor-β signaling and radioiodine resistance
    Hongwei Gao et al, 2020, J. Biol. Chem. CrossRef
20. Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment
    Li-Juan Deng et al, 2020, European Journal of Pharmacology CrossRef
21. Anticancer and Antiviral Properties of Cardiac Glycosides: A Review to Explore the Mechanism of Actions
    Dhanasekhar Reddy et al, 2020, Molecules CrossRef
22. Bufalin: A Systematic Review of Research Hotspots and Antitumor Mechanisms by Text Mining and Bioinformatics
    Xian Zhang et al, 2020, Am. J. Chin. Med. CrossRef
23. Anticancer activities of TCM and their active components against tumor metastasis.
    Kailong Wang et al, 2021, Biomed Pharmacother CrossRef
24. Bufalin inhibits the malignant development of non-small cell lung cancer by mediating the circ_0046264/miR-522-3p axis
    Jing Jin et al, 2021, Biotechnol Lett CrossRef
25. Anti-Cancer Effects of Glaucarubinone in the Hepatocellular Carcinoma Cell Line Huh7 via Regulation of the Epithelial-To-Mesenchymal Transition-Associated Transcription Factor Twist1
    Jihye Seo et al, 2021, IJMS CrossRef
26. Emergence of Cardiac Glycosides as Potential Drugs: Current and Future Scope for Cancer Therapeutics.
    Ranjith Kumavath et al, 2021, Biomolecules CrossRef
27. Modified Sijunzi Decoction Inhibits Epithelial-Mesenchymal Transition of Non-Small Cell Lung Cancer by Attenuating AKT/GSK3β Pathway in vitro and in vivo
    Niu Shao et al, 2022, Front. Pharmacol. CrossRef
28. Panax Notoginseng Saponins Regulate Transforming Growth Factor-β1 through MAPK and Snail/TWIST1 Signaling Pathway to Inhibit Epithelial-Mesenchymal Transition of Pulmonary Fibrosis in A549 Cells
    VietDung Nguyen et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
29. Agmatinase facilitates the tumorigenesis of pancreatic adenocarcinoma through the TGFβ/Smad pathway.
    Yue Zhang et al, 2022, Exp Ther Med CrossRef
30. Bufalin for an innovative therapeutic approach against cancer
    Laura Soumoy et al, 2022, Pharmacological Research CrossRef
31. Bufalin-Mediated Regulation of Cell Signaling Pathways in Different Cancers: Spotlight on JAK/STAT, Wnt/β-Catenin, mTOR, TRAIL/TRAIL-R, and Non-Coding RNAs
    Ammad Ahmad Farooqi et al, 2023, Molecules CrossRef
32. Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT)
    Mona Tangsiri et al, 2024, Biomedicine & Pharmacotherapy CrossRef
33. Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini
    Qian Zuo et al, 2024, Chin. J. Integr. Med. CrossRef
34. The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy.
    Iván Carrera-Aguado et al, 2024, Int J Mol Sci CrossRef
35. Exploiting Transcription Factors to Target EMT and Cancer Stem Cells for Tumor Modulation and Therapy
    Abdul Q. Khan et al, 2024, Seminars in Cancer Biology CrossRef
36. Therapeutic vulnerabilities in triple negative breast cancer: Stem-like traits explored within molecular classification
    Peng Huang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
37. Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review
    Sajad Fakhri et al, 2024, Cancer Metastasis Rev CrossRef
38. Bufalin Suppresses Head and Neck Cancer Development by Modulating Immune Responses and Targeting the β-Catenin Signaling Pathway
    Nour Mhaidly et al, 2024, Cancers CrossRef